Acer Therapeutics Inc. (ACER) News

Acer Therapeutics Inc. (ACER): $2.06

0.06 (+3.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter ACER News Items

ACER News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ACER News Highlights

  • For ACER, its 30 day story count is now at 2.
  • Over the past 6 days, the trend for ACER's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • APTX are the most mentioned tickers in articles about ACER.

Latest ACER News From Around the Web

Below are the latest news stories about Acer Therapeutics Inc that investors may wish to consider to help them evaluate ACER as an investment opportunity.

Is Opexa Therapeutics, Inc. (ACER) Outperforming Other Medical Stocks This Year?

Here is how Opexa Therapeutics, Inc. (ACER) and Aptinyx Inc. (APTX) have performed compared to their sector so far this year.

Yahoo | January 13, 2022

We're Interested To See How Acer Therapeutics (NASDAQ:ACER) Uses Its Cash Hoard To Grow

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | January 7, 2022

Acer Therapeutics to Participate in January 2022 Virtual Investor Conferences

NEWTON, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will participate in the upcoming 11th Annual LifeSci Partners Corporate Access virtual event and the H.C. Wainwright BioConnect Virtual Conference. Conference:11th Annual LifeSci Part

Yahoo | December 22, 2021

Comparing Acer Therapeutics (NASDAQ:ACER) and CV Sciences (OTCMKTS:CVSI)

Acer Therapeutics (NASDAQ:ACER) and CV Sciences (OTCMKTS:CVSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk. Profitability This table compares Acer Therapeutics and CV Sciences net margins, return on equity and []

Dakota Financial News | December 12, 2021

Acer Therapeutics (NASDAQ:ACER) Stock Rating Upgraded by Zacks Investment Research

Acer Therapeutics (NASDAQ:ACER) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The companys product pipeline consists of []

Transcript Daily | December 9, 2021

Acer Therapeutics Announces ACER-801 IND Clearance for the Treatment of Induced Vasomotor Symptoms

Phase 2a trial initiation expected in Q1 2022

Intrado Digital Media | December 9, 2021

Acer Therapeutics wins FDA nod for hot flashes trial

No summary available.

Seeking Alpha | December 9, 2021

-$0.24 Earnings Per Share Expected for Acer Therapeutics Inc. (NASDAQ:ACER) This Quarter

Equities analysts expect that Acer Therapeutics Inc. (NASDAQ:ACER) will announce earnings of ($0.24) per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Acer Therapeutics earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.22). Acer Therapeutics posted earnings of ($0.50) per share during the same []

Dakota Financial News | December 5, 2021

Vanguard Group Inc. Boosts Stock Holdings in Acer Therapeutics Inc. (NASDAQ:ACER)

Vanguard Group Inc. grew its stake in shares of Acer Therapeutics Inc. (NASDAQ:ACER) by 6.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 179,143 shares of the biopharmaceutical companys stock after acquiring an additional 11,094 shares during the period. [] The post Vanguard Group Inc. Boosts Stock Holdings in Acer Therapeutics Inc. (NASDAQ:ACER) appeared first on ETF Daily News .

ETF Daily News | November 29, 2021

5 Stocks To Watch For November 22, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Agilent Technologies, Inc. (NYSE: A) to report quarterly earnings at $1.03 per share on revenue of $1.45 billion before the opening bell. Agilent shares rose 0.4% to $164.90 in after-hours trading. NIO Inc. (NYSE: NIO) shares dropped more than 9% in the week ending Nov. 19, underperforming most of its electric-vehicle peers. The stock, however, saw an upward bounce in late trading on Friday as the company announced Fr

Yahoo | November 22, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5845 seconds.